Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of GEN1047 in Subjects With Malignant Solid Tumors

NCT05180474 is registered in ClinicalTrials.gov with Genmab as lead sponsor.

NCT NCT05180474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05180474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of GEN1047 in Subjects With Malignant Solid Tumors
Lead sponsor
Genmab
Phase
Phase 1/2
Overall status
Terminated
Start date
December 13, 2021
Completion date
March 25, 2026
Enrollment
179 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast neoplasms, endometrial cancer, endometrial neoplasm, ovarian cancer, ovarian neoplasms, squamous non small cell lung cancer (nsclc-scc)